2024
DOI: 10.3390/ijms25020791
|View full text |Cite
|
Sign up to set email alerts
|

Spice Up Your Kidney: A Review on the Effects of Capsaicin in Renal Physiology and Disease

Michela Musolino,
Mario D’Agostino,
Mariateresa Zicarelli
et al.

Abstract: Capsaicin, the organic compound which attributes the spicy flavor and taste of red peppers and chili peppers, has been extensively studied for centuries as a potential natural remedy for the treatment of several illnesses. Indeed, this compound exerts well-known systemic pleiotropic effects and may thus bring important benefits against various pathological conditions like neuropathic pain, rhinitis, itching, or chronic inflammation. Yet, little is known about the possible biological activity of capsaicin at th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 97 publications
0
1
0
Order By: Relevance
“…Furthermore, we identified several potential drug targets, such as L-aspartic acid, capsaicin, and 5-fluorouracil ( Figure 4 ). Remarkably, capsaicin has shown therapeutic potential in managing kidney diseases attributed to its diverse biological actions [ 48 ]. Experimental evidence suggests that capsaicin may slow the progression of CKD by inhibiting key fibrotic signaling pathways, notably TGF-β1 and Smad2/3, and by activating the TRPV1 channel [ 49 , 50 , 51 , 52 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, we identified several potential drug targets, such as L-aspartic acid, capsaicin, and 5-fluorouracil ( Figure 4 ). Remarkably, capsaicin has shown therapeutic potential in managing kidney diseases attributed to its diverse biological actions [ 48 ]. Experimental evidence suggests that capsaicin may slow the progression of CKD by inhibiting key fibrotic signaling pathways, notably TGF-β1 and Smad2/3, and by activating the TRPV1 channel [ 49 , 50 , 51 , 52 ].…”
Section: Discussionmentioning
confidence: 99%